PubMed Health⌕ Search

Biomedical subjects

J C Vidal

Publications and source records attributed to J C Vidal.

At least 37 records · Page 2Linked to original sources
PubMed1986

Contribution of phospholipase A2 to the lethal potency of Bothrops alternatus (víbora de la cruz) venom.

Purified phospholipase A2 from Bothrops alternatus venom is one single protein species with a molecular weight of 15,000 and isoelectric point 5.08. When injected i.p. or i.v. at a dose of 0.7 microgram/g body weight it is lethal to mice, eliciting a typical syndrome of dyspnea, tachycardia, arrhythmia and irreversible shock. Post mortem and histopathologic studies have demonstrated that the lungs (massive pulmonary hemorrhage), heart (foci of myocardial and endocardial necrosis with interfibrillar hemorrhage), liver (congestion, hepatocytic microvacuolization with zones of massive necrosis) and kidneys (foci of tubular and glomerular necrosis) were severely injured. Except for the less extensive hemorrhages and the significantly longer survival time, the observed lesions are similar to those observed after the injection of lethal doses of whole venom. The lethal potency of the purified enzyme (LD50 i.p. 0.14 microgram/g body weight) is 46-fold greater than that of the whole venom (LD50 i.p. 6.4 micrograms/g body weight). The contribution of phospholipase A2 to the overall lethal effect of B. alternatus venom is suggested by the decreased lethal potency of a venom sample in which a significant amount of phospholipase A2 has been removed and the full restoration of the lethal potency upon supplementation of the depleted sample with purified enzyme. It is concluded that phospholipase A2 is a major component responsible for lethality of the whole B. alternatus venom, while the contribution of other venom components appears to be significant mainly in reducing the time of survival.

Animals↗
PubMed1986

Phospholipase A2 from Bothrops alternatus (víbora de la cruz) venom. Purification and some characteristic properties.

One single protein species with phospholipase activity has been isolated from Bothrops alternatus venom by a procedure involving gel-filtration on Sephadex G-50 (Step 1), chromatography on SP-Sephadex C-50 (Step 2) and gel-filtration on Sephadex G-75 (Step 3). The purified sample behaved as a homogeneous, monodisperse protein with a molecular weight of 15,000 and isoelectric point of 5.04. The yield in enzyme activity was 48% of the starting material and the apparent purification was 51-fold. When assayed on 1,2-diheptanoyl- or 1,2-dimyristoyl-sn-glycero-3-phosphorylcholine, fatty acids and lysolecithins were the only reaction products, in accordance with the predicted stoichiometry. Studies on positional specificity suggested that the enzyme is a phospholipase A2. The enzyme requires Ca2+ ions for activity and exhibited stereochemical specificity, since the enantiomeric 2, 3-diheptanoyl-sn-glycero-1-phosphorylcholine was not hydrolyzed. Under the experimental conditions employed, reaction products representative of either phospholipase B or C activities could not be detected. After Step 1, the phospholipase activity recovered was higher than the total activity in the crude venom sample, which is explained by the separation of an inhibitor during enzyme purification. The inhibitor was responsible for the initial lag period that characterized the kinetics of the enzyme reaction with crude venom acting on aggregated substrates (lipoprotein, vesicles or micelles), while the rate of hydrolysis of monomeric lecithins was not affected.

Animals↗
PubMed1985

Dissociation of the crotoxin complex promoted by acetylcholine.

Neuromuscular blockage at the presynaptic level is the main biological effect exerted by crotoxin, the major toxin from Crotalus durissus terrificus venom. This effect requires the dissociation of this complex at the target membrane in spite of its tightness and stability under physiological conditions of pH, ionic composition and temperature. Complex dissociation should be determined by a specific set of physicochemical conditions prevailing at the neuromuscular junction. In this regard, we have studied the effect of acetylcholine on the stability of the crotoxin complex, since this effector is present at relatively high concentrations near the presynaptic membrane of the neuromuscular junction. Evidences arising from spectrofluorometric measurements, changes in enzymatic activity and crotoxin B inactivation by b-bromophenacyl bromide indicate that acetylcholine is indeed able to promote complex dissociation at neutral pH values, apparently by titration of 2-3 carboxylate groups in crotoxin A. This effect may, at least in part, contribute in determining the target specificity of this toxin.

Acetylcholine↗
PubMed1984

Pseudocooperative effects in reactivation of membrane-bound enzymes with phospholipids.

The kinetic mechanism for reactivation of membrane-bound enzymes by lipids is analyzed on the basis of multiple equilibriums between the enzyme (which is assumed to contain n identical, non-interacting binding sites) and the lipid. The rate equations derived when only the fully occupied enzyme species ELn (or ELn and the next most highly occupied species ELn-1, ELn-2,..., ELn-i) is catalytically active can fully account for the apparent positive cooperativity observed in the plots of enzyme activity as a function of phospholipid concentration. A general equation for the cases in which more than one lipid species are simultaneously present in the reaction medium is presented which allows to test whether the binding sites are indeed non-interacting, as well as whether the active species have the same catalytic constant (kcat), regardless the nature of the lipid bound to the binding sites. This analysis demonstrates that, in addition to apparent positive cooperativity, more complex curves resembling mixed cooperativity may be obtained with simple systems when interaction between protein subunits (i.e., association-dissociation equilibriums) are present. Finally, some theoretical problems and pitfalls in the interpretation of the experimental results will be discussed.

Binding Sites↗
PubMed1983

Influence of diabetes on rat liver mitochondria: decreased unsaturation of phospholipid and D-beta-hydroxybutyrate dehydrogenase activity.

Liver mitochondria and submitochondrial vesicles have been prepared from rats made diabetic by treatment with streptozotocin (diabetic membranes). The membranes were characterized in terms of phospholipid and fatty acid composition, electron transport functions, and D-beta-hydroxybutyrate dehydrogenase activity and compared with mitochondria and submitochondrial vesicles prepared from control animals (control membranes). No change in the phospholipid composition (44% lecithin, 35% phosphatidylethanolamine, and 21% diphosphatidylglycerol) was found, but a marked alteration in fatty acid composition of both the total phospholipid and lecithin occurred within 3 weeks after streptozotozin treatment and persisted thereafter. In lecithin, the 18:1/18:0 ratio decreases approximately 33% and the 20:4/18:2 ratio decreases approximately 55%. D-beta-hydroxybutyrate dehydrogenase is a lipid-requiring enzyme which has a specific requirement of lecithin for function. In diabetic membranes, there is a progressive decrease in D-beta-hydroxybutyrate dehydrogenase activity with time after streptozotocin treatment to about 40% of control value at 15 weeks. In contrast, succinate oxidase and succinate- or NADH-cytochrome c reductase activities remain essentially unaltered. Further, the Arrhenius plot characteristics differ for D-beta-hydroxybutyrate dehydrogenase in diabetic membranes as compared with control membranes, in that the break point of the biphasic plot increases from 20 +/- 1 degree C in controls to 29 +/- 1 degree C in samples from diabetic animals. The change occurs about 3 weeks after streptozotocin treatment and is correlatable with the increased saturation of the fatty acid moiety of the phospholipids. The observed changes in D-beta-hydroxybutyrate dehydrogenase function and phospholipid composition were prevented by administration of insulin to the diabetic animals and are therefore referable to insulin insufficiency.

Animals↗
PubMed1983

Basis for decreased D-beta-hydroxybutyrate dehydrogenase activity in liver mitochondria from diabetic rats.

Liver mitochondria from rats made diabetic with streptozotocin have a reduced level of D-beta-hydroxybutyrate dehydrogenase (BDH) activity and decreased ratios of oleic/stearic and arachidonic/linoleic acids in the phospholipids of the mitochondrial membrane. This altered activity and lipid environment result from insulin deprivation since maintenance of the diabetic rats on insulin leads to normal characteristics (J.C. Vidal, J.O. McIntyre, P.F. Churchill, and S. Fleischer (1983) Arch. Biochem, Biophys. 224, 643-658). In the present study, the basis for the reduced enzymatic activity of this lipid-requiring enzyme was analyzed using three approaches: (i) Purified D-beta-hydroxybutyrate, dehydrogenase was inserted into membranes from mitochondria, submitochondrial vesicles, and mitochondrial lipids extracted therefrom. The activation was the same and optimal irrespective of whether the preparations were derived from normal or diabetic rat liver. Therefore, the decreased activity does not appear to be referable to an altered lipid composition. (ii) BDH activity can be released from the mitochondria by phospholipase A2 digestion. The released activity was proportional to the endogenous activity in the submitochondrial vesicles from normal and diabetic membranes. (iii) The BDH activity in submitochondrial vesicles was titrated by inhibition with specific antiserum. Less enzyme was found in mitochondria from diabetic rats as compared with those from normal animals. Hence, the lowered enzymatic activity is due to decreased enzyme in the mitochondrial inner membrane and not to the modified lipid environment.

Animals↗
PubMed1983

Kinetic studies on the reactivation of D-beta-hydroxybutyrate dehydrogenase with mixtures of short-chain lecithins.

D-beta-hydroxybutyrate dehydrogenase, purified as soluble, lipid-free apoenzyme (inactive) from rat liver mitochondria can be reactivated by the short-chain dihexanoyl, diheptanoyl, and dioctanoyl lecithins at the monomeric state, upon formation of a reversible enzyme-lecithin complex. Previous studies with these lecithins suggested that reactivation of the apoenzyme requires the simultaneous occupation of two identical, noninteracting lecithin binding sites via a rapid equilibrium random mechanism. The short-chain lecithins exhibited similar reactivating capacities, differing only in their affinities towards the enzyme. In order to further test that model, the reactivation of the apoenzyme was studied when two or three short-chain lecithins were simultaneously present in the reaction medium. The initial velocities were measured either as a function of the concentration of one lecithin while the other(s) were kept constant, or as a function of the total phospholipid concentration with mixtures of different lecithins at a constant molar ratio. The pertinent equations were derived on the principles of multiple equilibria with identical, noninteracting sites able to be occupied by any of the different lecithins present in the reaction medium, with the doubly occupied enzyme as the only active species. In agreement with the above-proposed model, the results obtained indicates that the molar fraction of the doubly occupied (active) enzyme species can be calculated from equilibrium considerations and that the maximal attainable with the different short-chain lecithins are similar.

Animals↗
PubMed1983

The mechanism of inhibition of phospholipase activity of crotoxin B by crotoxin A.

In the crotoxin complex isolated from Crotalus durissus terrificus venom, the component A inhibits the phospholipase A2 activity of crotoxin B only when the substrate is in the aggregated form, preventing the interaction of the enzyme with lecithin--water interfaces. In contrast, with similar rates of hydrolysis of dihexanoyllecithin monomers, the activity of the crotoxin complex is lower than that of crotoxin B when the substrate is aggregated into micelles. Crotoxin B readily hydrolyses dimyristoyllecithin vesicles, the rate being modulated by the physical state of the phospholipid, suggesting that the enzyme is tightly bound to the interface. With the crotoxin complex the rate of vesicle hydrolysis is much slower (about 1/10 that of crotoxin B) and is little affected by the physical state of the lecithin. Direct binding experiments demonstrate that, in contrast to crotoxin B, the crotoxin complex is unable to interact with lecithin--water interfaces. Together with the free accessibility of the enzyme active site in the crotoxin complex, this evidence suggests that a specific area on the enzyme surface, different from the active site and shielded by crotoxin A in the complex, is responsible for the interaction of crotoxin B with lipid--water interfaces.

Crotalid Venoms↗
PubMed1982

Reactivation of D-beta-hydroxybutyrate dehydrogenase with short-chain lecithins: stoichiometry and kinetic mechanism.

D-beta-Hydroxybutyrate dehydrogenase (BDH), purified as soluble, lipid-free apoenzyme (inactive) from either beef heart or rat liver mitochondria, can be reactivated by short-chain lecithins in the monomeric state. The enzyme was reactivated with dihexanoyl- [PC(6:0)], diheptanoyl- [PC(7:0)], and dioctanoyllecithins [PC(8:0)]. The titration curves of enzyme activity as a function of the phospholipid concentration are consistent with a model in which the enzyme contains two identical, noninteracting lecithin binding sites. The simultaneous occupation of these sites (via an equilibrium random mechanism) is required to activate the apoenzyme. Similar results were obtained with both rat liver and beef heart apoenzymes. The maximal velocities obtained with the different lecithins were similar [110-140 mumol of NAD+ reduced min-1 (mg of protein)-1]. The KL values (the apparent dissociation constants of the lecithin-site complexes) were 1.2 X 10(-4) M [PC(8:0)], 1.5 X 10(-3) M [PC(7:0)], and 4.5 X 10(-3) M [PC(6:0)] at 37 degrees C. This was confirmed by using phospholipase A2 to compete with the dehydrogenase for the lecithin monomers. Comparison of the delta G degrees values for complex formation with the different lecithins shows an average contribution of approximately 2.4 kJ/mol (0.9RT) per CH2 group. The interaction of the apolar moiety of lecithin with the protein seems to be essential for effective binding of phosphatidylcholine to apoBDH. The delta G degrees values, when combined with the estimated delta H degrees values, suggest that the binding of lecithin to the apoenzyme is approximately 60% enthalpy and approximately 40% entropy driven.

Animals↗
PubMed1982

Accessibility of the active site of crotoxin B in the crotoxin complex.

Basic phospholipases A and the crotoxin complex isolated from Crotalus durissus terrificus venom exhibited similar initial reaction rates, time course and degree of hydrolysis of synthetic short chain lecithins in the monomeric state. Although monomeric lecithins seem to promote dissociation of crotoxin up to a certain extent, this cannot explain the high activity observed with the complex. The crotoxin complex is able to bind the non-hydrolyzable analog D-diheptanoyllecithin, as demonstrated by equilibrium gel-filtration, with a dissociation constant of 0.12 mM. This value is similar to the dissociation constant of the crotoxin B-D-diheptanoyllecithin complex (about 0.13 mM), estimated from the protection against enzyme inactivation by p-bromophenacyl bromide, which further supports the free accessibility of the substrate to the enzyme active site in the crotoxin complex. The lack of enzyme inactivation when crotoxin is treated with p-bromophenacyl bromide may be interpreted in terms of the specific requirements of the reagent to react with the enzyme rather than protection of the active site. Crotoxin B inhibition by complex formation with crotoxin A, which is not apparent on monomeric substrates, seems not to involve the active site of the enzyme.

Acetophenones↗
PubMed1982

[Resistance of Crotalus durissus terrificus and Bothrops neuwiedii to the neurotoxicity of massive quantities of Crotalid venom].

The antitoxic potency of crude Crotalus durissus terrificus serum against crotalic venom is similar to that of a standard horse anticrotalic serum in protecting mice against 4 LD50, while the potency of Bothrops neuwiedii serum is 20% of the latter. Failure to form precipitin lines in immunodiffusion tests suggests that the antitoxic factors present in the sera from both species are not immunoglobulins. It is, therefore, probable that crotoxin is not neutralized by an antigen-antibody reaction, but rather by formation of inactive complexes with specific serum components. Resistance to the venom is not reciprocal, since specimens of C. d. terrificus die after the injection of similar amounts of B. neuwiedii venom, which are tolerated by the homologous species.

Animals↗
PubMed1981

Kinetic analysis of enzyme inhibition by substrate depletion.

A novel treatment for the inhibition of an enzyme-catalyzed reaction due to a ligand that combines with the substrate to form a non-productive inhibitor-substrate complex is presented. When compared to the conventional kinetic treatment of substrate depletion systems, the treatment presented here has two major advantages, namely (a) it is of general validity since no approximations are required for derivation of the pertinent equations; and (b) establishes a linear relationship between the reciprocal concentration of substrate-inhibitor complex and the ratio of free enzyme to enzyme-substrate complex concentrations, thus giving linear plots which allow the direct computation of the Km/Ki ratio. With purified enzyme preparations, this treatment allows the calculation of the absolute concentrations of all the species present in the reaction medium, although a purified preparation is not a pre-requisite for its applicability. The presented treatment has its most useful application in re-testing the Km value of an enzyme-catalyzed reaction when other experimental approaches cannot be employed.

Enzyme Inhibitors↗